136 related articles for article (PubMed ID: 28065979)
1. A word of caution regarding pioglitazone.
Usman MS; Rizwan T; Ahmed F
J Pak Med Assoc; 2017 Jan; 67(1):153. PubMed ID: 28065979
[No Abstract] [Full Text] [Related]
2. Pioglitazone and bladder cancer: FDA's assessment.
Hampp C; Pippins J
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):117-118. PubMed ID: 28067434
[No Abstract] [Full Text] [Related]
3. The impact of pioglitazone on bladder cancer and cardiovascular events.
Lee EJ; Marcy TR
Consult Pharm; 2014 Aug; 29(8):555-8. PubMed ID: 25203263
[TBL] [Abstract][Full Text] [Related]
4. Bladder Cancer In Patients With Type 2 Diabetes Treated With Pioglitazone, A Comparative Study.
Riaz A; Khan K; Afreen B; Kazmi I
J Ayub Med Coll Abbottabad; 2018; 30(3):356-359. PubMed ID: 30465366
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of observational studies of the association between pioglitazone use and bladder cancer.
Ripamonti E; Azoulay L; Abrahamowicz M; Platt RW; Suissa S
Diabet Med; 2019 Jan; 36(1):22-35. PubMed ID: 30378165
[TBL] [Abstract][Full Text] [Related]
6. Prescribing trend of pioglitazone after safety warning release in Korea.
Jeong HE; Cho SI; Oh IS; Baek YH; Shin JY
Am J Manag Care; 2019 Nov; 25(11):e342-e348. PubMed ID: 31747239
[TBL] [Abstract][Full Text] [Related]
7. Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes.
Fujimoto K; Hamamoto Y; Honjo S; Kawasaki Y; Mori K; Tatsuoka H; Matsuoka A; Wada Y; Ikeda H; Fujikawa J; Koshiyama H
Diabetes Res Clin Pract; 2013 Feb; 99(2):e21-3. PubMed ID: 23228390
[TBL] [Abstract][Full Text] [Related]
8. Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type-2 diabetes.
Garry EM; Buse JB; Gokhale M; Lund JL; Nielsen ME; Pate V; Stürmer T
Diabetes Obes Metab; 2019 Sep; 21(9):2096-2106. PubMed ID: 31087620
[TBL] [Abstract][Full Text] [Related]
9. Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes.
Qu H; Zheng Y; Wang Y; Zhang R; Ruan X; Yang G; Liu Z; Zheng H
Sci Rep; 2017 Nov; 7(1):15804. PubMed ID: 29150684
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone and bladder cancer: the pros and cons.
Panikar V
J Assoc Physicians India; 2012 Jan; 60():72-3. PubMed ID: 22715550
[No Abstract] [Full Text] [Related]
11. Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis.
Zhu Z; Shen Z; Lu Y; Zhong S; Xu C
Diabetes Res Clin Pract; 2012 Oct; 98(1):159-63. PubMed ID: 22705039
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone and bladder cancer risk: a systematic review and meta-analysis.
Tang H; Shi W; Fu S; Wang T; Zhai S; Song Y; Han J
Cancer Med; 2018 Apr; 7(4):1070-1080. PubMed ID: 29476615
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies.
Ferwana M; Firwana B; Hasan R; Al-Mallah MH; Kim S; Montori VM; Murad MH
Diabet Med; 2013 Sep; 30(9):1026-32. PubMed ID: 23350856
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone and the risk of bladder cancer.
Hillaire-Buys D; Faillie JL
BMJ; 2012 May; 344():e3500. PubMed ID: 22653979
[No Abstract] [Full Text] [Related]
15. Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer.
Lewis JD; Habel L; Quesenberry C; Mamtani R; Peng T; Bilker WB; Hedderson M; Nessel L; Vaughn DJ; Strom BL; Ferrara A
Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):636-45. PubMed ID: 24764283
[TBL] [Abstract][Full Text] [Related]
16. Balancing the risks and benefits for pioglitazone in type 2 diabetes.
Johnson JA; Colmers IN
Diabetes Res Clin Pract; 2012 Oct; 98(1):1-2. PubMed ID: 22959125
[No Abstract] [Full Text] [Related]
17. Pioglitazone Use and Risk of Bladder Cancer.
Davies BJ
JAMA; 2015 Dec; 314(23):2568. PubMed ID: 26670977
[No Abstract] [Full Text] [Related]
18. Pioglitazone Use and Risk of Bladder Cancer.
Singh S; Suchard MA
JAMA; 2015 Dec; 314(23):2567-8. PubMed ID: 26670976
[No Abstract] [Full Text] [Related]
19. Pleural Effusion Due to Use of Pioglitazone: A Case Report.
Xue J; Liu W; Shi F; Zheng J; Ma J
Metab Syndr Relat Disord; 2020 Apr; 18(3):168-171. PubMed ID: 32250209
[No Abstract] [Full Text] [Related]
20. Pioglitazone for diabetes prevention.
Goldstein MR; Mascitelli L
N Engl J Med; 2011 Jul; 365(2):183; author reply 183-4. PubMed ID: 21751925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
